Signaling Through NK Cell-Associated CD137 Promotes Both Helper Function for CD8+ Cytolytic T Cells and Responsiveness to IL-2 But Not Cytolytic Activity1

NK cells possess both effector and regulatory activities that may be important during the antitumor immune response. In fact, the generation of antitumor immunity by the administration of an agonistic mAb against CD137 is NK cell-dependent. In this study, we report that NK cells could be induced by IL-2 and IL-15 to express CD137 and ligation of CD137-stimulated NK cell proliferation and IFN-γ secretion, but not their cytolytic activity. Importantly, CD137-stimulated NK cells promoted the expansion of activated T cells in vitro, demonstrating immunoregulatory or “helper” activity for CD8+CTL. Furthermore, tumor-specific CTL activity against P815 tumor Ags was abrogated following anti-CD137 treatment in NK-depleted mice. We further demonstrate that CD137-stimulated helper NK cells expressed the high-affinity IL-2R and were hyperresponsive to IL-2. Taken together with previous findings that CD137 is a critical receptor for costimulation of T cells, our findings suggest that CD137 is a stimulatory receptor for NK cells involved in the crosstalk between innate and adaptive immunity.

[1]  Lieping Chen,et al.  Cutting Edge: Expression of Functional CD137 Receptor by Dendritic Cells1 , 2002, The Journal of Immunology.

[2]  Aaron J. Johnson,et al.  Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. , 2002, The Journal of clinical investigation.

[3]  A. Diefenbach,et al.  Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity , 2001, Nature.

[4]  M. Debenedette,et al.  4-1BB Ligand Induces Cell Division, Sustains Survival, and Enhances Effector Function of CD4 and CD8 T Cells with Similar Efficacy1 , 2001, The Journal of Immunology.

[5]  C. Takahashi,et al.  Differential clonal expansion of CD4 and CD8 T cells in response to 4-1BB ligation: contribution of 4-1BB during inflammatory responses. , 2001, Immunology letters.

[6]  M. Soloski Recognition of tumor cells by the innate immune system. , 2001, Current opinion in immunology.

[7]  J. Peschon,et al.  Ligation of 4-1BB (CDw137) Regulates Graft-Versus-Host Disease, Graft-Versus-Leukemia, and Graft Rejection in Allogeneic Bone Marrow Transplant Recipients1 , 2001, The Journal of Immunology.

[8]  L. Lanier,et al.  Immune inhibitory receptors. , 2000, Science.

[9]  N. Shastri,et al.  Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages , 2000, Nature Immunology.

[10]  T. Mcclanahan,et al.  Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. , 2000, Immunity.

[11]  A. Sette,et al.  4-1BB Costimulation Is Required for Protective Anti-Viral Immunity After Peptide Vaccination1 , 2000, The Journal of Immunology.

[12]  Mamoru Ito,et al.  CD27-Mediated Activation of Murine NK Cells1 , 2000, The Journal of Immunology.

[13]  R. Glas,et al.  Recruitment and Activation of Natural Killer (Nk) Cells in Vivo Determined by the Target Cell Phenotype , 2000, The Journal of experimental medicine.

[14]  G. Sica,et al.  Modulation of the immune response through 4-1BB. , 2000, Advances in experimental medicine and biology.

[15]  M. Bachmann,et al.  Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. , 1999, Journal of immunology.

[16]  A Steinle,et al.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.

[17]  Jun Wu,et al.  An activating immunoreceptor complex formed by NKG2D and DAP10. , 1999, Science.

[18]  H. Warren,et al.  Quantitative analysis of the effect of CD16 ligation on human NK cell proliferation. , 1999, Journal of Immunology.

[19]  Lieping Chen,et al.  NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. , 1998, Cellular immunology.

[20]  M. Smyth,et al.  An Essential Role for Tumor Necrosis Factor in Natural Killer Cell–mediated Tumor Rejection in the Peritoneum , 1998, The Journal of experimental medicine.

[21]  T. Mak,et al.  CD28-independent, TRAF2-dependent Costimulation of Resting T Cells by 4-1BB Ligand , 1998, The Journal of experimental medicine.

[22]  F. Kos Regulation of adaptive immunity by natural killer cells , 1998, Immunologic research.

[23]  Lieping Chen,et al.  Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors , 1997, Nature Medicine.

[24]  C. Biron Activation and function of natural killer cell responses during viral infections. , 1997, Current opinion in immunology.

[25]  T. Mak,et al.  Costimulation of CD28- T lymphocytes by 4-1BB ligand. , 1997, Journal of immunology.

[26]  E. Engleman,et al.  Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. , 1996, Cellular immunology.

[27]  T. Whiteside,et al.  Divergent effects of FcγRIIIA ligands on the functional activities of human natural killer cells in vitro , 1996, European journal of immunology.

[28]  E. Engleman,et al.  Requirement for natural killer cells in the induction of cytotoxic T cells. , 1995, Journal of immunology.

[29]  M. Harada,et al.  Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes. , 1995, Immunology.

[30]  G. Trinchieri Natural killer cells wear different hats: effector cells of innate resistance and regulatory cells of adaptive immunity and of hematopoiesis. , 1995, Seminars in immunology.

[31]  M. Caligiuri,et al.  Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor , 1994, The Journal of experimental medicine.

[32]  W. Seaman,et al.  Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules. , 1992, Journal of immunology.

[33]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.

[34]  R. Herberman,et al.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells , 1975, International journal of cancer.

[35]  R. Herberman,et al.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity , 1975, International journal of cancer.

[36]  R. Kiessling,et al.  „Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype , 1975, European journal of immunology.

[37]  R. Kiessling,et al.  „Natural”︁ killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell , 1975, European journal of immunology.